Hepatitis C Full Studies On HBV/HCV

[Guest guest]

Hepatitis C Full Studies On HBV/HCV

How to use virological tools for the optimal management of chronic hepatitis C (pages 3–12)

Philipp de Leuw, Christoph Sarrazin and Stefan ZeuzemArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02398.x Abstract Full Article (HTML) PDF(240K) References

You have free access to this content

How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? (pages 13–17)

t Castera and Pierre BedossaArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02380.x Abstract Full Article (HTML) PDF(127K) References

You have free access to this content

Impact of a sustained virological response on the long-term outcome of hepatitis C (pages 18–22)

Alfredo AlbertiArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02378.x Abstract Full Article (HTML) PDF(124K) References

State of the art lecture You have free access to this content

Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C (pages 23–28)

Arun J. SanyalArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02397.x Abstract Full Article (HTML) PDF(202K) References

Hepatitis C: towards a personalised management You have free access to this content

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care (pages 29–35)

G. McHutchisonArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02389.x Abstract Full Article (HTML) PDF(174K) References

Optimising therapy in real life You have free access to this content

Optimal therapy in hepatitis C virus genotypes 2 and 3 patients (pages 36–44)

Salvatore Petta and CraxìArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02382.x Abstract Full Article (HTML) PDF(155K) References

You have free access to this content

Hepatitis C virus genotype 4 therapy: progress and challenges (pages 45–52)

Sanaa M. KamalArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02385.x Abstract Full Article (HTML) PDF(193K) References

You have free access to this content

The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naïve patients (pages 53–57)

R. Article first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02391.x Abstract Full Article (HTML) PDF(173K) References

You have free access to this content

The role of triple therapy in HCV genotype 1-experienced patients (pages 58–61)

W. FriedArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02410.x Abstract Full Article (HTML) PDF(213K) References

The future You have free access to this content

Future hepatitis C virus treatment: interferon-sparing combinations (pages 62–67)

GaneArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02383.x Abstract Full Article (HTML) PDF(264K) References

You have free access to this content

New direct-acting antivirals' combination for the treatment of chronic hepatitis C (pages 68–77)

Tarik Asselah and MarcellinArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02411.x Abstract Full Article (HTML) PDF(752K) References

HBeAg-positive chronic hepatitis B You have free access to this content

Chronic hepatitis B: peginterferon or nucleos(t)ide analogues? (pages 78–84)

Milan J. Sonneveld and Harry L. A. JanssenArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02384.x Abstract Full Article (HTML) PDF(195K) References

You have free access to this content

Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues (pages 85–89) LeungArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02387.x Abstract Full Article (HTML) PDF(131K) References

You have free access to this content

Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon (pages 90–94)

Pietro Lampertico, Mauro Viganò and Massimo ColomboArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02386.x Abstract Full Article (HTML) PDF(223K) References

You have free access to this content

Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues (pages 95–103)

V. PapatheodoridisArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02392.x Abstract Full Article (HTML) PDF(214K) References

Special populations You have free access to this content

The difficulties of managing severe hepatitis B virus reactivation (pages 104–110)

Bruno Roche and Didier Article first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02396.x Abstract Full Article (HTML) PDF(205K) References

Hepatitis B: towards a personalised You have free access to this content

Hepatitis B virus resistance to antiviral drugs: where are we going? (pages 111–116)

Fabien ZoulimArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02399.x Abstract Full Article (HTML) PDF(153K) References

Hepatitis B: towards a personalised management You have free access to this content

Impact of hepatitis B therapy on the long-term outcome of liver disease (pages 117–121)

Yun-Fan LiawArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02388.x Abstract Full Article (HTML) PDF(126K) References

Hepatitis B: towards a personalised You have free access to this content

Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B (pages 122–128)

Rami Moucari and MarcellinArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02390.x Abstract Full Article (HTML) PDF(178K) References

Hepatitis B: towards a personalised management You have free access to this content

Milestones and perspectives in viral hepatitis B (pages 129–134)

Stephanos J. HadziyannisArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02406.x Abstract Full Article (HTML) PDF(141K) References

Special populations You have free access to this content

The impact of human immunodeficiency virus on viral hepatitis (pages 135–139)

Mallet, Anaïs Vallet-Pichard and Stanislas PolArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02394.x Abstract Full Article (HTML) PDF(226K) References

You have free access to this content

Hepatitis D revival (pages 140–144)

Heiner WedemeyerArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02408.x Abstract Full Article (HTML) PDF(150K) References

Management of hepatocellular carcinoma You have free access to this content

How I manage my patients with hepatocellular carcinoma (pages 145–150)

Massimo Colombo and Angelo SangiovanniArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02381.x Abstract Full Article (HTML) PDF(279K) References

You have free access to this content

Novel molecular therapies in hepatocellular carcinoma (pages 151–160)

Sandrine Faivre, Mohamed Bouattour and Article first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02395.x Abstract Full Article (HTML) PDF(170K) References

You have free access to this content

Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome? (pages 161–163)

Jacques Belghiti and François DurandArticle first published online: 4 JAN 2011 DOI: 10.1111/j.1478-3231.2010.02413.x Abstract Full Article (HTML) PDF(109K) References

http://Hepatitis Cnewdrugs.blogspot.com/2011/01/hepatitis-c-full-studies-on-hbvhcv.html